Drug Enforcement Administration October 2013 – Federal Register Recent Federal Regulation Documents

Manufacturer of Controlled Substances; Notice of Application; Cedarburg Pharmaceuticals, Inc.
Document Number: 2013-25102
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; GE Healthcare
Document Number: 2013-25101
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration, Siegfried USA, LLC
Document Number: 2013-25098
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Stepan Company
Document Number: 2013-25097
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Boehringer Ingelheim Chemicals, Inc.
Document Number: 2013-25096
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Watson Pharma, Inc.
Document Number: 2013-25094
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Cambrex Charles City, Inc.
Document Number: 2013-25091
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Siegfried (USA), LLC
Document Number: 2013-25090
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Pharmacore, Inc.
Document Number: 2013-25088
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Stepan Company
Document Number: 2013-25087
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Boehringer Ingelheim Chemicals
Document Number: 2013-25086
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Research Triangle Institute
Document Number: 2013-25085
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration, Penick Corporation
Document Number: 2013-25084
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Akorn, Inc.
Document Number: 2013-25081
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Nektar Therapeutics
Document Number: 2013-25079
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Agilent Technologies
Document Number: 2013-25078
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Application, Wildlife Laboratories, Inc.
Document Number: 2013-25077
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2013-25076
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Siegfried USA, LLC
Document Number: 2013-25075
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; United States Pharmacopeial Convention
Document Number: 2013-25073
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration, Austin Pharma, LLC.
Document Number: 2013-25072
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Noramco, Inc.
Document Number: 2013-25069
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Noramco, Inc. (GA)
Document Number: 2013-25067
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Penick Corporation
Document Number: 2013-25064
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Cambrex Charles City, Inc.
Document Number: 2013-25062
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Chemtos, LLC
Document Number: 2013-25060
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Ronald F. Lambert, D.D.S.; Decision and Order
Document Number: 2013-24698
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
Mark G. Medinnus, D.D.S.; Decision and Order
Document Number: 2013-24697
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
Morris W. Cochran, M.D.; Decision and Order
Document Number: 2013-24696
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
Kenneth Harold Bull, M.D.; Decision and Order
Document Number: 2013-24695
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
Anthony E. Wicks, M.D. Decision and Order
Document Number: 2013-24694
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
Hoi Y. Kam, M.D.; Decision and Order
Document Number: 2013-24627
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
Lannett Company, Inc.; Grant of Registration To Import Schedule I Substance
Document Number: 2013-24621
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Perampanel into Schedule III
Document Number: 2013-24600
Type: Proposed Rule
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to place the substance perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2- dihydropyridin-3-yl) benzonitrile hydrate], including its salts, isomers, and salts of isomers, into Schedule III of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Assistant Secretary for Health of the Department of Health and Human Services (HHS) and on an evaluation of all other relevant data by the DEA. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions of Schedule III controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, and possess) or propose to handle perampanel.
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Phenethylamines Into Schedule I
Document Number: 2013-24432
Type: Proposed Rule
Date: 2013-10-10
Agency: Drug Enforcement Administration, Department of Justice
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to temporarily schedule three synthetic phenethylamines into the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5), 2-(4- chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82), and 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) [hereinafter 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe]. This action is based on a finding by the Deputy Administrator that the placement of these synthetic phenethylamines into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. Any final order will be published in the Federal Register and may not be issued prior to November 12, 2013. Any final order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to Schedule I substances under the CSA on the manufacture, distribution, possession, importation, exportation, research, and conduct of instructional activities of these synthetic phenethylamines.
Joe W. Morgan, D.O.; Decision and Order
Document Number: 2013-24400
Type: Notice
Date: 2013-10-08
Agency: Drug Enforcement Administration, Department of Justice
Decision and Order: Clair L. Pettinger, M.D.
Document Number: 2013-24052
Type: Notice
Date: 2013-10-03
Agency: Drug Enforcement Administration, Department of Justice